% | $
Quotes you view appear here for quick access.

International Stem Cell Corporation Message Board

  • headsupeyesclosed headsupeyesclosed Apr 29, 2010 1:17 AM Flag


    Should creep up on BTIM if things go their way. With so many big pharma hurting for new products I suspect ISCO should cut a deal with Pfizer or the like.

    The differentiated derivatives of human parthenogenetic stem cells, obtained by ISCO scientists, promise to overcome the problem of immune-matching in tissue-replacement therapy. This is a significant differentiator from embryonic stem cells and a major reason why hpSC have the potential to become the first population-specific pluripotent stem cells available for use in the treatment of human diseases for different genders and racial groups across the world.

    This achievement is another step toward the creation by ISCO of its proprietary “UniStem Cell Bank”™, confirming the importance of human parthenogenetic stem cells in possible therapeutic application and their ability to meet clinical transplant standards.

    SortNewest  |  Oldest  |  Most Replied Expand all replies